{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:32:27Z","timestamp":1792798347791,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AstraZeneca"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03358-8","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:07:38Z","timestamp":1761653258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy"],"prefix":"10.1186","volume":"26","author":[{"given":"Pierachille","family":"Santus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Oresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiuseppe","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Caplen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Carioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Pyenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"10","key":"3358_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14100979","volume":"14","author":"SO Rodrigues","year":"2021","unstructured":"Rodrigues SO, Cunha CMCD, et al. Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease. Pharmaceuticals. 2021;14(10):1\u201332.","journal-title":"Pharmaceuticals"},{"key":"3358_CR2","doi-asserted-by":"crossref","unstructured":"Putcha N, Drummond MB, Wise RA, Hansel NN, et al. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2016;36(4).","DOI":"10.1055\/s-0035-1556063"},{"key":"3358_CR3","unstructured":"Global Strategy for Prevention. Diagnosis and Management of COPD: 2023 Report. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2023;1:1\u2013205."},{"key":"3358_CR4","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2025 report. S.l. Global Initiative for Chronic Obstructive Lung Disease; 2025:1\u2013215."},{"key":"3358_CR5","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.2147\/COPD.S370540","volume":"17","author":"MG David","year":"2022","unstructured":"David MG, Halpin DMG, Rothnie KJ, et al. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis. 2022;17:2417\u201329.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"5","key":"3358_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.chest.2022.06.033","volume":"162","author":"Bernardino Alc\u00e1zar-Navarrete","year":"2022","unstructured":"Alc\u00e1zar-Navarrete Bernardino, Jamart Luc\u00eda. Clinical, characteristics. Treatment persistence, and outcomes among patients with COPD treated with single- or multiple-inhaler triple therapy: a retrospective analysis in Spain. Chest. 2022;162(5):1017\u201329.","journal-title":"Chest"},{"key":"3358_CR7","doi-asserted-by":"crossref","unstructured":"Deslee G, Fabry-Vendrand C, Poccardi N, Thabut G, Eteve Pitsaer C, Coriat A, Renaudat C, Maguire A, Pinto T. Use and persistence of Single and multiple inhaler triple therapy prescribed for patients with COPD in france: a retrospective study on THIN database (OPTI study). BMJ Open Respir Res. 10(1):1\u201310.","DOI":"10.1136\/bmjresp-2022-001585"},{"issue":"1","key":"3358_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1916046","volume":"383","author":"KF Rabe","year":"2020","unstructured":"Rabe KF, Martinez FJ, Ferguson GT, et al. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe. COPD N Engl J Med. 2020;383(1):35\u201348.","journal-title":"COPD. N Engl J Med."},{"issue":"18","key":"3358_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"DA Lipson","year":"2018","unstructured":"Lipson DA, Barnhart F, Brealey N, et al. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. N Engl J Med. 2018;378(18):1671\u201380.","journal-title":"N Engl J Med."},{"key":"3358_CR10","unstructured":"Societ\u00e0 Italiana di Medicina Generale e delle Cure Primarie. HS-Newsletter. 2020. https:\/\/www.healthsearch.it\/documenti\/documenti_ricercatori\/Newsletter\/2020\/1_2020.pdf.\u00a0Cited 2024 Nov 25."},{"key":"3358_CR11","unstructured":"Global health estimates. Leading causes of death. World Health Organisation. https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/ghe-leading-causes-of-death.\u00a0Cited 2024 Nov 25."},{"key":"3358_CR12","doi-asserted-by":"crossref","unstructured":"Santus P, et al. Exacerbation burden in COPD and occurrence of mortality in a cohort of Italian patients: results of the gulp study. Int J Chron Obstruct Pulmon Dis. 2024;19:607\u201318.","DOI":"10.2147\/COPD.S446636"},{"key":"3358_CR13","doi-asserted-by":"crossref","unstructured":"Dal Negro RW. COPD: the annual cost-of-illness during the last two decades in Italy, and its mortality predictivity power. Healthcare. 2019;7(1).","DOI":"10.3390\/healthcare7010035"},{"key":"3358_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03339-5","author":"Giulia Ronconi","year":"2024","unstructured":"Ronconi Giulia. Clinical characteristics. Use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare data. BMC Pulm Med. 2024. https:\/\/doi.org\/10.1186\/s12890-024-03339-5.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"3358_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.36469\/001c.55635","volume":"10","author":"G Criner","year":"2023","unstructured":"Criner G, Martinez F, et al. PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population. J Health Econ Outcomes Res. 2023;10(1):20\u20137.","journal-title":"J Health Econ Outcomes Res."},{"key":"3358_CR16","doi-asserted-by":"crossref","unstructured":"Soler-Catalu\u00f1a JJ, et al. Impact of COPD exacerbations and burden of disease in Spain: AVOIDEX study. Int J Chron Obstruct Pulmon Dis. 2023;18:1103\u201314.","DOI":"10.2147\/COPD.S406007"},{"key":"3358_CR17","doi-asserted-by":"crossref","unstructured":"Radovanovic D, Contoli M, et al. Clinical and functional characteristics of COPD patients across GOLD classifications: results of a multicenter observational study. COPD. 201916(3-4):215\u201326.","DOI":"10.1080\/15412555.2019.1659760"}],"updated-by":[{"DOI":"10.1186\/s12931-026-03896-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000}}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03358-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:45:50Z","timestamp":1790055950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3358"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03358-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the incorrect figure 3 and 4 was corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12931-026-03896-9","URL":"https:\/\/doi.org\/10.1186\/s12931-026-03896-9","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pierachille Santus and Alberto Papi have been remunerated for validating assumptions, sources, and interpreting results of the present work. Bianca Oresta, Davide Finocchiaro, Piergiuseppe De Rosa, and John Bell are employees of AstraZeneca and may hold stock and\/or stock options in the company. Melissa Caplen, Jennifer Carioto, Prachi Bhatt, and Bruce Pyenson are employees of Milliman, which was contracted by AstraZeneca to conduct this study. The American Academy of Actuaries requires its members to identify their credentials in their work product. Bruce Pyenson, Jennifer Carioto, and Melissa Caplen are members of the American Academy of Actuaries and meet its relevant qualification requirements.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"296"}}